Patent Assignment
Reel/Frame 060410/0839
Release of Security Interest
Recorded: 2022-07-06
Pages: 17
Assignor
OXFORD FINANCE LLC
Executed: 2021-10-12
Assignee
OBSEVA S.A.
CHEMIN DES AULX 12, PLAN-LES-OUATES, 1228, SWITZERLAND
Covered Properties
(13)
Pyrrolidine Derivatives as Oxytocin/Vasopressin V1A Receptors Antagonists
Pyrrolidine Derivatives as Oxytocin/Vasopressin V1A Receptors Antagonists
Application:
14/917,847 →
Publication:
US 2016/0221944
Pyrrolidine Derivatives as Oxytocin/Vasopressin V1A Receptors Antagonists
Pyrrolidine Derivatives as Oxytocin/Vasopressin V1A Receptors Antagonists
Oral Formulations of Pyrrolidine Derivatives
Oral Formulations of Pyrrolidine Derivatives
Application:
15/104,683 →
Publication:
US 2017/0065556
Oral Formulations of Pyrrolidine Derivatives
Crystalline (3Z,5S)-5-(Hydroxymethyl)-1-[(2'-Methyl-1,1'-Biphenyl-4-Yl)Carbonyl]Pyrrolidin-3-One O-Methyloxime, and Methods of Using the Same
Crystalline (3Z,5S)-5-(Hydroxymethyl)-1-[(2'-Methyl-1,1'-Biphenyl-4-Yl)Carbonyl]Pyrrolidin-3-One O-Methyloxime, and Methods of Using the Same
Oxytocin Antagonist Dosing Regimens for Promoting Embryo Implantation and Preventing Miscarriage
Application:
16/318,413 →
Publication:
US 2019/0247361
Alpha-Amino Esters of Hydroxypropylthiazolidine Carboxamide Derivative and Salt Form, Crystal Polymorph Thereof
Compositions and Methods for the Treatment or Prevention of Preterm Labor
Application:
62/672,278 →
Compositions and Methods for Delaying the Incidence of Labor
Patent:
11,534,428 →
Application:
16/411,974 →
Related Assignments
(21)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 18, 2014
From: CHOLLET, ANDRE
To: OBSEVA S.A.
Reel/Frame 033767/0517 →
Assignment of Assignor's Interest
Jan 15, 2015
From: CHOLLET, ANDRE; POHL, OLIVER
To: OBSEVA S.A.
Reel/Frame 034719/0736 →
Assignment of Assignor's Interest
Jul 14, 2015
From: CHOLLET, ANDRÉ
To: OBSEVA SA
Reel/Frame 036076/0248 →
Assignment of Assignor's Interest
Jun 6, 2016
From: CHOLLET, ANDRE
To: OBSEVA S.A.
Reel/Frame 038814/0564 →
Assignment of Assignor's Interest
Feb 2, 2017
From: CHOLLET, ANDRE; POHL, OLIVER
To: OBSEVA S.A.
Reel/Frame 041157/0909 →
Assignment of Assignor's Interest
Sep 22, 2017
From: CHOLLET, ANDRE
To: OBSEVA S.A.
Reel/Frame 043669/0042 →
Assignment of Assignor's Interest
Mar 9, 2018
From: CHOLLET, ANDRÉ
To: OBSEVA S.A.
Reel/Frame 045161/0780 →
Assignment of Assignor's Interest
May 29, 2018
From: POHL, OLIVER; GOTTELAND, JEAN-PIERRE
To: OBSEVA S.A.
Reel/Frame 045922/0978 →
Assignment of Assignor's Interest
Jun 22, 2018
From: CHOLLET, ANDRE
To: OBSEVA S.A.
Reel/Frame 046180/0015 →
Assignment of Assignor's Interest
Jun 22, 2018
From: CHOLLET, ANDRE; POHL, OLIVER
To: OBSEVA S.A.
Reel/Frame 046180/0075 →
Assignment of Assignor's Interest
Jul 9, 2018
From: POMEL, VINCENT
To: MERCK SERONO S.A.
Reel/Frame 046296/0640 →
Assignment of Assignor's Interest
Jul 9, 2018
From: SCHWARZ, MATTHIAS
To: MERCK SERONO S.A.
Reel/Frame 046296/0706 →
Assignment of Assignor's Interest
Jul 9, 2018
From: PAGE, PATRICK; JORAND-LEBRUN, CATHERINE; QUATTROPANI, ANNA
To: MERCK SERONO S.A.
Reel/Frame 046296/0859 →
Assignment of Assignor's Interest
Jul 9, 2018
From: LOUMAYE, ERNEST; POHL, OLIVER; GOTTELAND, JEAN-PIERRE
To: OBSEVA S.A.
Reel/Frame 046297/0015 →
Assignment of Assignor's Interest
Jul 9, 2018
From: MERCK SERONO S.A.
To: OBSEVA S.A.
Reel/Frame 046297/0091 →
Assignment of Assignor's Interest
May 10, 2019
From: LOUMAYE, ERNEST; GOTTELAND, JEAN-PIERRE
To: OBSEVA S.A.
Reel/Frame 049137/0846 →
Security Interest
Aug 7, 2019
From: OBSEVA SA
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 049994/0930 →
Assignment of Assignor's Interest
Jan 21, 2020
From: GOTTELAND, JEAN-PIERRE; POHL, OLIVER
To: OBSEVA S.A.
Reel/Frame 051571/0406 →
Assignment of Assignor's Interest
Nov 21, 2022
From: OBSEVA S.A.
To: XOMA (US) LLC
Reel/Frame 061844/0880 →
Assignment of Assignor's Interest
Jan 8, 2026
From: OBSEVA SA
To: REPRONOVO SA
Reel/Frame 074301/0001 →
Security Interest
Jul 14, 2026
From: CYDEX PHARMACEUTICALS, INC.; LIGAND PHARMACEUTICALS INCORPORATED; METABASIS THERAPEUTICS, INC.; XOMA (US) LLC
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 075969/0966 →